News & Events about Exelixis Inc.
Funds managed by Farallon Capital Management, L.L.C. (Farallon) own approximately 7.2% of the outstanding shares of Exelixis, Inc. (NASDAQ: EXEL) (Exelixis or the Company), making it the Companys largest active shareholder. Today, Farallon filed definitive proxy materials in connection with...
TipRanks Financial Blog
1month ago
In a report released yesterday, Chris Shibutani from Goldman Sachs maintained a Sell rating on Exelixis (EXEL Research Report). The companys sha... In a report released yesterday, Chris Shibutani from Goldman Sachs maintained a Sell rating on Exelixis (EXEL –...
StockNews.com upgraded shares of Exelixis (NASDAQ:EXEL Get Rating) from a hold rating to a buy rating in a research report sent to investors on Wednesday morning. EXEL has been the topic of several other research reports. EF Hutton Acquisition Co. I reaffirmed a buy rating and issued a $24.00 price ...
Diversified Trust Co purchased a new position in Exelixis, Inc. (NASDAQ:EXEL Get Rating) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 19,811 shares of the biotechnology companys stock, valued at...
Business Wire
2 months ago
Exelixis, Inc. (Nasdaq: EXEL) today announced that the companys Board of Directors has authorized the repurchase of up to $550 million of the companys common stock before the end of 2023. The timing and amount of any share repurchases under the share repurchase program will be based on a variety...